# Cyprotex US LLC

Canonical: https://abierto.us/vendors/cyprotex-us-llc-ynglsaf57t14

- UEI: YNGLSAF57T14
- CAGE: 47UC6
- Location: Watertown, MA
- Awards in window: 15 (29 transactions), $671,249 obligated, February 1, 2024 to September 14, 2026

## Awarding agencies

- Departmental Offices: 5 awards, $496,160
- Food and Drug Administration: 1 awards, $70,500
- National Institutes of Health: 7 awards, $54,589
- Environmental Protection Agency: 2 awards, $50,000

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $496,160
- 541380 Testing Laboratories and Services: $110,559
- 541690 Other Scientific and Technical Consulting Services: $70,500
- 541990 All Other Professional, Scientific, and Technical Services: -$5,970

## Competition

- Full and Open Competition: 5 awards
- Not Competed Under SAP: 5 awards
- Competed Under SAP: 3 awards
- Not Competed: 2 awards

## Solicitations won

- In vitro testing services for small-molecule drug candidates (75N98026Q00482). https://abierto.us/opportunities/75n98026q00482
- EPA High Throughput Toxicokinetics (HTTK) (140D0424F0309), $44,744. https://abierto.us/opportunities/140d0424f0309

## Largest awards

- 140D0425F0082 (delivery order): $451,818, Ibc Acq SVCS Directorate. High Throughput Toxicokinetics (Httk) - Task Order #7. https://www.usaspending.gov/award/CONT_AWD_140D0425F0082_1406_140D0420D0003_1406/
- 75N98026P00718 (purchase order): $77,897, National Institutes of Health Olao. Nci: Service: in Vitro Drug Candidate Testing: Non-Severable. https://www.usaspending.gov/award/CONT_AWD_75N98026P00718_7529_-NONE-_-NONE-/
- 75F40126P00176 (purchase order): $70,500, FDA Office of Acq Grant SVCS. Eo 14398 - Purchase of Development of a Human Neural Network Formation New Approach Method for the Evaluation of Potential Developmental Neurotoxicity. https://www.usaspending.gov/award/CONT_AWD_75F40126P00176_7524_-NONE-_-NONE-/
- 68HE0B25P0230 (purchase order): $50,000, Ord Simplified Acq Branch (Sab). Testing of Compounds in Human Neurite Outgrowth Assay (Adme-Tox Services). https://www.usaspending.gov/award/CONT_AWD_68HE0B25P0230_6800_-NONE-_-NONE-/
- 140D0424F0309 (delivery order): $44,744, Ibc Acq SVCS Directorate. EPA -Toxicokinetic Testing. https://www.usaspending.gov/award/CONT_AWD_140D0424F0309_1406_140D0420D0003_1406/
- 68HE0B23P0636 (purchase order): $0, Ord Simplified Acq Branch (Sab). Unilateral Modification P00001 to Po # 68he0b23p0636 to Extend Ending Pop. Testing Chemicals in Network Formation Assay. https://www.usaspending.gov/award/CONT_AWD_68HE0B23P0636_6800_-NONE-_-NONE-/
- 140D0420D0003: $0, Ibc Acq SVCS Directorate. High Throughput Toxicokinetics (Httk). Adds a Clause to the Contract.. https://www.usaspending.gov/award/CONT_IDV_140D0420D0003_1406/
- 75N95020P00056 (purchase order): -$60, National Institutes of Health Nida. Testing of 100 Compounds for Cyp Inhibition. https://www.usaspending.gov/award/CONT_AWD_75N95020P00056_7529_-NONE-_-NONE-/
- 140D0424F0076 (delivery order): -$168, Ibc Acq SVCS Directorate. EPA -Toxicokinetic Testing- Extension of Period of Performance End Date. https://www.usaspending.gov/award/CONT_AWD_140D0424F0076_1406_140D0420D0003_1406/
- 140D0423F0254 (delivery order): -$234, Ibc Acq SVCS Directorate. High Throughput Toxicokinetics (Httk) Task Order #4. https://www.usaspending.gov/award/CONT_AWD_140D0423F0254_1406_140D0420D0003_1406/
- 75N95023P00020 (purchase order): -$280, National Institutes of Health Nida. FY26 Udo Initiative - Testing of Compounds in Caco-2 Assays. https://www.usaspending.gov/award/CONT_AWD_75N95023P00020_7529_-NONE-_-NONE-/
- 75N95022P00601 (purchase order): -$738, National Institutes of Health Nida. FY26 Udo Initiative - Testing of Compounds in Cyp Inhibition, Herg Inhibition, Ppb, and Caco-2 Permeability Assays. https://www.usaspending.gov/award/CONT_AWD_75N95022P00601_7529_-NONE-_-NONE-/
- 75N95020P00597 (purchase order): -$5,970, National Institutes of Health Nida. To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2020 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2025, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N95020P00597_7529_-NONE-_-NONE-/
- 75N95021P00593 (purchase order): -$7,830, National Institutes of Health Nida. To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N95021P00593_7529_-NONE-_-NONE-/
- 75N95019P00369 (purchase order): -$8,430, National Institutes of Health Nida. Bioanalysis Testing Services. https://www.usaspending.gov/award/CONT_AWD_75N95019P00369_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/cyprotex-us-llc-ynglsaf57t14.